Wai Chun Bio-Technology (00660.HK): Appointed Exclusive Overseas General Agent for China's Leading Crane Manufacturer; Three-Year Agreement

NewTimeSpace News: Wai Chun Bio-Technology signs exclusive overseas general agency agreement with Henan Mine Crane for global markets excluding mainland China; three-year term with renewal rights; licensor is a leading Chinese crane manufacturer with annual revenue of approximately RMB 6.5 billion; company adopts a light-asset model with autonomous pricing to capture global infrastructure demand.

NewTimeSpace News: Wai Chun Bio-Technology Limited (stock code: 660) announced that on 5 August 2026, it signed an Exclusive Overseas General Agency Agreement with Henan Mine Crane Co., Ltd., under which the company was appointed as the exclusive overseas general agent for crane and mining equipment products globally (excluding mainland China).

The agreement term is three years from 5 August 2026 to 5 August 2029, with priority renewal rights under equivalent conditions. The authorized products include "Kuangyuan" brand bridge cranes, gantry cranes, electric hoists and related mining equipment. The licensor, a leading Chinese crane manufacturer with annual revenue of approximately RMB 6.5 billion, will provide competitive "authorized agency floor prices"; the company has the right to independently determine final sales prices, with all sales premiums belonging to the company.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.

×
Share to WeChat

Open WeChat, use the "Scan", and share to my Moments.